补肾中药治疗不明原因复发性流产的潜在机制:胚胎着床与肿瘤侵袭同质性的临床证据
该研究通过系统评价与Meta分析评估补肾中药治疗不明原因复发性流产(URSA)的临床疗效,并利用网络分析与分子对接探讨其潜在机制。Meta分析纳入9项RCT共1054例受试者,显示补肾中药较对照组显著改善临床疗效。研究识别出32个潜在活血成分和113个主要靶点,关键通路为肿瘤相关信号通路,其调控的靶基因与肿瘤生物过程高度相似。
要点
- 补肾中药治疗URSA的Meta分析纳入9项RCT共1054例,临床疗效显著优于对照组。
- 关键生物活性分子包括Japonine、sopranol、赖氨酸和苦参碱。
- URSA的关键潜在治疗通路为肿瘤相关信号通路,与凋亡、炎症、血管生成等过程相似。
核心结论
- 补肾中药在治疗URSA方面具有较大潜力,其机制可能与调控肿瘤相关信号通路及凋亡、炎症、血管生成等生物过程有关。
研究设计与样本
- 系统检索PubMed、Embase、中国生物医学文献数据库、Web of Science、CNKI和万方数据库2010年1月至2021年6月发表的以补肾中药为基础治疗URSA的文献,并进行文献计量学分析。
- 选取RCT文章进行系统评价与Meta分析,纳入9项RCT共1054例受试者。
- 对高频补肾中药进行网络分析与分子对接研究关键成分和潜在通路。
主要发现
- 与对照组相比,补肾中药治疗URSA患者的临床疗效显著改善。
- 识别出包含32个潜在活血成分和113个主要靶点的成分-靶点-通路网络。
- Japonine、sopranol、赖氨酸和苦参碱被认为是补肾中药最重要的生物活性分子。
- URSA的关键潜在治疗通路为肿瘤相关信号通路,其调控的靶基因与肿瘤生物过程高度相似,如凋亡信号通路调节、炎症反应、血管生成和上皮代谢转化。
关键数值与推荐
- Meta分析纳入9项RCT,涉及1054例受试者。
- 网络分析识别出32个潜在活血成分和113个主要靶点。
- 关键生物活性分子包括Japonine、sopranol、赖氨酸和苦参碱。
临床怎么用
- 补肾中药可用于URSA患者的治疗,临床疗效显著优于对照组。
- 研究提示维持妊娠与肿瘤侵袭高度相似,肿瘤机制研究可为URSA研究提供新思路和突破。
- 未来可采用单细胞联合空间组学验证补肾中药治疗URSA的机制。
局限性
- 研究未报告纳入RCT的具体偏倚风险、异质性及发表偏倚评估结果。
- 网络分析与分子对接结果需进一步实验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Kidney-tonifying herbs (KTHs) are widely used to treat unexplained recurrent spontaneous abortion (URSA) based on the theory of traditional Chinese medicine (TCM). However, there is still a lack of systematic evaluation and mechanistic explanation for these treatments. Objective: The purpose of this study was to assess the clinical efficacy, and to investigate the potential mechanisms, of KTH based on TCM for the treatment of URSA. Methods: A systematic literature search was conducted within PubMed, Embase, China Biomedical Literature database, Web of Science (WOS), China National Knowledge Infrastructure (CNKI) database, and the Wanfang database to find articles reporting on the Chinese herbal formula based around KTH for treating URSA, which were published between January 2010 and June 2021. A full bibliometric analysis was carried out; in addition, randomized controlled trial (RCT) articles were selected for systematic evaluation and meta-analysis. The drugs with the highest frequency of KTHs were screened for meta-analysis. Finally, network analysis and molecular docking were used to study the key components and potential pathway of KTHs in the treatment of URSA. Results: The meta-analysis included nine RCTs involving 1,054 subjects. Compared with the control groups, the clinical efficacy of TCM-based KTHs in the treatment of URSA patients significantly improved outcomes. Additionally, a component target pathway network was identified, which included 32 potential blood activating components and 113 main targets. Japonine, sopranol, lysine, and matrine were considered the most important bioactive molecules for KTHs. The key potential therapeutic pathway for URSA was a tumor-related signaling pathway. The target genes for URSA regulated by KTHs were highly similar to tumor biological processes such as the regulation of apoptotic signaling pathways, inflammatory responses, angiogenesis, and epithelial metabolic transition. Conclusion: KTH has great potential for treating URSA. Because the maintenance of pregnancy has a high similarity with tumor invasion, the research relating to tumor mechanisms should also be followed up as it may lead to new ideas and breakthroughs for research into URSA. At the same time, embryonic and decidual cells share a high degree of cellular heterogeneity and spatial structural complexity with tumor cells, and a single cell combined with spatial omics may be the best future approach for validating KTH mechanisms.
引用
- Zhou H, Yang Y, Deng L, et al. A Potential Mechanism of Kidney-Tonifying Herbs Treating Unexplained Recurrent Spontaneous Abortion: Clinical Evidence From the Homogeneity of Embryo Implantation and Tumor Invasion. Front Pharmacol. 2022. PMID: 35153745. doi:10.3389/fphar.2021.775245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。